Skip to content

Extended Platelet Rich Fibrin or Hyaluronate Enriched Xenografts for Horizontal Ridge Augmentation Via Subperiosteal Tunneling

Extended Platelet Rich Fibrin or Hyaluronate Enriched Xenografts for Horizontal Ridge Augmentation Via Subperiosteal Tunneling

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07412535
Acronym
E-PRF
Enrollment
34
Registered
2026-02-17
Start date
2024-03-01
Completion date
2025-10-01
Last updated
2026-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant

Brief summary

Extended platelet rich fibrin or hyaluronate enriched xenografts will be used for horizontal maxillary ridge augmentation via subperiosteal tunneling to allow placement of dental implants six months later.

Interventions

COMBINATION_PRODUCTbovine bone mixed with hyaluronate

cerabone plus will be inserted as a graft material via subperiosteal tunneling of thin maxilla

COMBINATION_PRODUCTbovine bone mixed with E-PEF

bovine bone mixed with E-PEF will be inserted as a graft material via subperiosteal tunneling of thin maxilla

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* a maxillary anterior or premolar narrow ridge (width 3-6 mm), and adequate bone height (\>8 mm), seeking horizontal augmentation \& dental implant rehabilitation

Exclusion criteria

* systemic contraindications to surgery, local infection, untreated periodontal disease, heavy smoking, or pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
horizontal bone gain measurement6months, 12 monthsCBCT will be used to measure horizontal bone width of the surgical site (in mm) at 3 points: at level of the crest, 2 mm and 6mm apical to the crest.

Secondary

MeasureTime frameDescription
bone density measurement6 months, 12 monthsBone density will be assessed in HU by CBCT by using on demand 3D program

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026